Want to see AVIR full AI Analyst Report?
Atea Pharmaceuticals (AVIR) Income Statement
Atea Pharmaceuticals Income Statement
Last quarter (Q2 2026), Atea Pharmaceuticals's total revenue was $0.00. In Q2, Atea Pharmaceuticals's net income was $-32.93M. See Atea Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 351.37M | |
| $ 0.00 | $ -83.37M | $ -70.09M | $ -62.39M | $ 184.16M | |
| $ 180.89M | $ 109.58M | $ 94.07M | $ 68.26M | $ 45.78M | |
| Depreciation and Amortization | $ 416.00K | $ 416.00K | $ 416.00K | $ 260.00K | $ 29.00K |
| $ -164.09M | $ -131.80M | $ -119.59M | $ -110.84M | $ 138.62M | |
| $ -180.89M | $ -192.95M | $ -164.16M | $ -130.65M | $ 138.38M | |
| $ 16.38M | $ 25.49M | $ 29.22M | $ 11.15M | $ 213.00K | |
| $ -164.51M | $ -167.46M | $ -134.94M | $ -119.50M | $ 138.59M | |
| $ -158.35M | $ -168.38M | $ -135.96M | $ -115.91M | $ 121.19M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.94 | $ -2.00 | $ -1.63 | $ -1.39 | $ 1.46 |
| Diluted EPS | $ -1.94 | $ -2.00 | $ -1.63 | $ -1.39 | $ 1.37 |
| Weighted Average Shares Outstanding | 81.50M | 84.26M | 83.39M | 83.25M | 82.82M |
| Weighted Average Shares Outstanding (Diluted) | 81.50M | 84.26M | 83.39M | 83.25M | 88.25M |
Currency in USD